If you use a high quality “Point of Care” drug test device/kit, then they tend to be highly accurate by default. It should be noted that overall accuracy must include sensitivity and specificity and be calculated with both “positives” and “negatives”. E.g. You can have a strip that is claimed to be 100% accurate for “positives” because it is using a very high cut-off (i.e. low sensitivity) and cross-reacts to many “compounds” (i.e. low specificity). However – this strip would miss many “lower end positives” and can therefore impact on the integrity and effectiveness of the testing process and that of the Policy.
Accuracy, specificity and sensitivity figures, other important information and specification can be found on the ITS “Point of Care” drug test device/kit product insert contained in every box or available on request. Each strip and cut-off will have different data, so this will impact on the average overall accuracy depending on which combination of drugs are being tested for.
Police Scotland say 185 drivers failed roadside drug tests during their festive campaign. For the 1st time officers were able to test for drugs at the roadside. Drug tests for cannabis & cocaine resulted in 185 positive results from 480 drivers stopped. Almost 600 motorists breathalysed between 1 Dec-2 Jan were under the influence of drink/drugs. A total of 8687 drivers were stopped over the period, with 580 of those detected for drink/drug offences. 29 drivers were caught the morning after they had been drinking.
Charity Alcohol Change UK have announced Alcohol Awareness Week (AAW) 2019 will take place from 11-17 November. Are you / your workplace doing anything to support and promote Alcohol Awareness Week?
Pregabalin and Gabapentin to be controlled as class C drugs from April 2019 Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from April 2019, the government announced on 15 October 2018. The move comes after experts highlighted rising numbers of fatalities linked to the drugs. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.